5-Hydroxytryptamine induces mast cell adhesion and migration

Journal of Immunology

Volumn 177, Issue 9, 2006, Pages 6422-6432

  Kushnir Sukhov, Nataliya M ^a   Gilfillan, Alasdair M ^a   Coleman, John W ^a   Brown, Jared M ^a   Bruening, Sandra ^b   Toth, Miklos ^b   Metcalfe, Dean D ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; FIBRONECTIN; IMMUNOGLOBULIN E; MESSENGER RNA; PERTUSSIS TOXIN; SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR;

ACTIN POLYMERIZATION; ANIMAL CELL; ARTICLE; BONE MARROW CELL; CD34 SELECTION; CELL ADHESION; CELL MATURATION; CELL MIGRATION; CHEMOTAXIS; CONTROLLED STUDY; DERMIS; FEMALE; HUMAN; HUMAN CELL; INFLAMMATION; KNOCKOUT MOUSE; LEUKOCYTE ACTIVATION; MAST CELL; MAST CELL DEGRANULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RNA ANALYSIS; TISSUE INJURY;

EID: 33750327836     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.9.6422     Document Type: Article

References (56)

1. Galli, S. J., J. Wedemeyer, and M. Tsai. 2002. Analyzing the roles of mast cells and basophils in host defense and other biological responses. Int. J. Hematol. 75: 363-369.
2. Maurer, M., T. Theoharides, R. D. Granstein, S. C. Bischoff, J. Bienenstock, B. Henz, P. Kovanen, A. M. Piliponsky, N. Kambe, H. Vliagoftis, et al. 2003. What is the physiological function of mast cells? Exp. Dermatol. 12: 886-910.
3. Mekori, Y. A., and D. D. Metcalfe. 2000. Mast cells in innate immunity. Immunol. Rev. 173: 131-140.
4. Metcalfe, D. D., D. Baram, and Y. A. Mekori. 1997. Mast cells. Physiol. Rev. 77: 1033-1079.
5. Matsuda, H., H. Ushio, G. P. Geba, and P. W. Askenase. 1997. Human platelets can initiate T cell-dependent contact sensitivity through local serotonin release mediated by IgE antibodies. J. Immunol. 158: 2891-2897.
6. Lundeberg, L., E. Sundstrom, K. Nordlind, A. Verhofstad, and O. Johansson. 1999. Serotonin in human allergic contact dermatitis. Ann. NY Acad. Sci. 885: 422-426.
7. Lundeberg, L., H. El-Nour, S. Mohabbati, M. Morales, E. Azmitia, and K. Nordlind. 2002. Expression of serotonin receptors in allergic contact eczematous human skin. Arch. Dermatol. Res. 294: 393-398.
8. Lundeberg, L., Y. Liang, E. Sundstrom, K. Nordlind, A. Verhofstad, S. Liden, and O. Johansson. 1999. Serotonin in human allergic contact dermatitis: an immunohistochemical and high-performance liquid chromatographic study. Arch. Dermatol. Res. 291: 269-274.
9. Lechin, F., B. van der Dijs, B. Orozco, H. Jara, I. Rada, M. E. Lechin, and A. E. Lechin. 1998. Neuropharmacologic treatment of bronchial asthma with the antidepressant tianeptine: a double-blind, crossover placebo-controlled study. Clin. Pharmacol. Ther. 64: 223-232.
10. Levy, L. H., E. Mendes, and A. U. Cintra. 1961. 5-Hydroxytraptamine in the bronchial sputum of asthmatic patients. Acta Allergol. 16: 121-127.
11. Gresele, P., E. Ribaldi, S. Grasselli, T. Todisco, and G. G. Nenci. 1987. Evidence for platelet activation in allergic asthma. Agents Actions. Suppl. 21: 119-128.
12. Pitchford, S. C., H. Yano, R. Lever, Y. Riffo-Vasquez, S. Ciferri, M. J. Rose, S. Giannini, S. Momi, D. Spina, B. O'Connor, et al. 2003. Platelets are essential for leukocyte recruitment in allergic inflammation. J. Allergy Clin. Immunol. 112: 109-118.
13. Cazzola, I., and M. G. Matera. 2000. 5-HT modifiers as a potential treatment of asthma. Trends Pharmacol. Sci. 21: 13-16.
14. Cazzola, M., G. Assogna, G. Lucchetti, G. Cicchitto, and G. D'Amato. 1990. Effect of ketanserin, a new blocking agent of the 5-HT2 receptor, on airway responsiveness in asthma. Allergy 45: 151-153.
15. Raymond, J. R., Y. V. Mukhin, A. Gelasco, J. Turner, G. Collinsworth, T. W. Gettys, J. S. Grewal, and M. N. Garnovskaya. 2001. Multiplicity of mechanisms of serotonin receptor signal transduction. Pharmacol. Ther. 92: 179-212.
16. Betten, A., C. Dahlgren, S. Hermodsson, and K. Hellstrand. 2001. Serotonin protects NK cells against oxidatively induced functional inhibition and apoptosis. J. Leukocyte Biol. 70: 65-72.
17. Freire-Garabal, M., M. J. Nunez, J. Balboa, P. Lopez-Delgado, R. Gallego, T. Garcia-Caballero, M. D. Fernandez-Roel, J. Brenlla, and M. Rey-Mendez. 2003. Serotonin upregulates the activity of phagocytosis through 5-HT1A receptors. Eur. J. Pharmacol. 139: 457-463.
18. Idzko, M., E. Panther, C. Stratz, T. Muller, H. Bayer, G. Zissel, T. Durk, S. Sorichter, F. Di Virgilio, M. Geissler, et al. 2004. The serotoninergic receptors of human dendritic cells: identification and coupling to cytokine release. J. Immunol. 172: 6011-6019.
19. Boehme, S. A., F. M. Lio, L. Sikora, T. S. Pandit, K. Lavrador, S. P. Rao, and P. Sriramarao. 2004. Cutting edge: serotonin is a chemotactic factor for eosinophils and functions additively with eotaxin. J. Immunol. 173: 3599-3603.
20. Bondesson, L., K. Nordlind, V. Mutt, and S. Liden. 1996. Inhibitory effect of vasoactive intestinal polypeptide and ketanserin on established allergic contact dermatitis in man. Acta Derm. Venereol. 76: 102-106.
21. Iken, K., S. Chheng, A. Fargin, A. C. Goulet, and E. Kouassi. 1995. Serotonin upregulates mitogen-stimulated B lymphocyte proliferation through 5-HT1A receptors. Cell Immunol. 163: 1-9.
22. Parks, C. L., P. S. Robinson, E. Sibille, T. Shenk, and M. Toth. 1998. Increased anxiety of mice lacking the serotonin1A receptor. Proc. Natl. Acad. Sci. USA 95: 10734-10739.
23. Tkaczyk, C., V. Horejsi, S. Iwaki, P. Draber, L. E. Samelson, A. B. Satterthwaite, D. H. Nahm, D. D. Metcalfe, and A. M. Gilfillan. 2004. NTAL phosphorylation is a pivotal link between the signaling cascades leading to human mast cell degranulation following Kit activation and FcεRI aggregation. Blood 104: 207-214.
24. Weller, C. L., S. J. Collington, J. K. Brown, H. R. Miller, A. Al-Kashi, P. Clark, P. J. Jose, A. Hartnell, and T. J. Williams. 2005. Leukotriene B4, an activation product of mast cells, is a chemoattractant for their progenitors. J. Exp. Med. 201: 1961-1971.
25. Tkaczyk, C., Y. Okayama, D. D. Metcalfe, and A. M. Gilfillan. 2004. Fcγ receptors on mast cells: activatory and inhibitory regulation of mediator release. Int. Arch. Allergy Immunol. 133: 305-315.
26. +, and expresses aminopeptidase N (CD13). Blood 94: 2333-2342.
27. Kulka, M., and D. D. Metcalfe. 2005. High-resolution tracking of cell division demonstrates differential effects of TH1 and TH2 cytokines on SCF-dependent human mast cell production in vitro: correlation with apoptosis and Kit expression. Blood 105: 592-599.
28. + pluripotent progenitor cells. Methods Mol. Biol. 315: 105-112.
29. + cells: comparisons with tumor mast-cell lines. J. Immunol. 166: 6647-6656.
30. Kulka, M., L. Alexopoulou, R. A. Flavell, and D. D. Metcalfe. 2004. Activation of mast cells by double-stranded RNA: evidence for activation through Toll-like receptor 3. J. Allergy Clin. Immunol. 114: 174-182.
31. Okayama, Y., C. Tkaczyk, D. D. Metcalfe, and A. M. Gilfillan. 2003. Comparison of FcεRI- and FcγRI-mediated degranulation and TNF-α synthesis in human mast cells: selective utilization of phosphatidylinositol-3- kinase for FcγRI-induced degranulation. Eur. J. Immunol. 33: 1450-1459.
32. Liao, F., A. K. Shirakawa, J. F. Foley, R. L. Rabin, and J. M. Farber. 2002. Human B cells become highly responsive to macrophage-inflammatory protein-3α/CC chemokine ligand-20 after cellular activation without changes in CCR6 expression or ligand binding. J. Immunol. 168: 4871-4880.
33. Tkaczyk, C., D. D. Metcalfe, and A. M. Gilfillan. 2002. Determination of protein phosphorylation in FcεRI-activated human mast cells by immunoblot analysis requires protein extraction under denaturing conditions. J. Immunol. Methods 268: 239-243.
34. Tkaczyk, C., M. A. Beaven, S. M. Brachman, D. D. Metcalfe, and A. M. Gilfillan. 2003. The phospholipase Cγ1-dependent pathway of FcεRI-mediated mast cell activation is regulated independently of phosphatidylinositol 3-kinase. J. Biol. Chem. 278: 48474-48484.
35. Vliagoftis, H. 2002. Thrombin induces mast cell adhesion to fibronectin: evidence for involvement of protease-activated receptor-1. J. Immunol. 169: 4551-4558.
36. Ebersole, B. J., C. A. Diglio, D. W. Kaufman, and K. A. Berg. 1993. 5-Hydroxytryptamine1-like receptors linked to increases in intracellular calcium concentration and inhibition of cyclic AMP accumulation in cultured vascular smooth muscle cells derived from bovine basilar artery. J. Pharmacol Exp. Ther. 266: 692-699.
37. Frevert, C. W., V. A. Wong, R. B. Goodman, R. Goodwin, and T. R. Martin. 1998. Rapid fluorescence-based measurement of neutrophil migration in vitro. J. Immunol. Methods 213: 41-52.
38. Dastych, J., D. Taub, M. C. Hardison, and D. D. Metcalfe. 1998. Tyrosine kinase-deficient Wv c-kit induces mast cell adhesion and chemotaxis. Am. J. Physiol. 275: C1291-C1299.
39. Vega, E., and M. I. Rudolph. 2002. Characterization of oxytocin receptors and serotonin transporters in mast cells. Endocrine 18: 167-172.
40. Huang, J., G. Li, J. Xiang, D. Yin, and R. Chi. 2004. Immunohistochemical study of serotonin in lesions of psoriasis. Int. J. Dermatol. 43: 408-411.
41. + pluripotent progenitor cells. J. Immunol. 148: 772-777.
42. Mekori, Y. A., C. K. Oh, and D. D. Metcalfe. 1993. IL-3-dependent murine mast cells undergo apoptosis on removal of IL-3: prevention of apoptosis by c-kit ligand. J. Immunol. 151: 3775-3784.
43. Wingren, U., A. Wasteson, and L. Enerback. 1983. Storage and turnover of histamine, 5-hydroxytryptamine and heparin in rat peritoneal mast cells in vivo. Int. Arch. Allergy Appl. Immunol. 70: 193-199.
44. Kushnir-Sukhov, N. M., J. M. Brown, Y. Wu, A. Kirshenbaum, and D. D. Metcalfe. 2006. Human mast cells are capable of serotonin synthesis and release. J. Allergy Clin. Immunol. In press.
45. Kraft, S., T. Fleming, J. M. Billingsley, S. Y. Lin, M. H. Jouvin, P. Storz, and J. P. Kinet. 2005. Anti-CD63 antibodies suppress IgE-dependent allergic reactions in vitro and in vivo. J. Exp. Med. 201: 385-396.
46. Swindle, E. J., J. A. Hunt, and J. W. Coleman. 2002. A comparison of reactive oxygen species generation by rat peritoneal macrophages and mast cells using the highly sensitive real-time chemiluminescent probe pholasin: inhibition of antigen-induced mast cell degranulation by macrophage-derived hydrogen peroxide. J. Immunol. 169: 5866-5873.
47. Taylor, A. M., S. J. Galli, and J. W. Coleman. 1995. Stem-cell factor, the kit ligand, induces direct degranulation of rat peritoneal mast cells in vitro and in vivo: dependence of the in vitro effect on period of culture and comparisons of stem-cell factor with other mast cell-activating agents. Immunology 86: 427-433.
48. Aune, T. M., H. W. Golden, and K. M. McGrath. 1994. Inhibitors of serotonin synthesis and antagonists of serotonin IA receptors inhibit T lymphocyte function in vitro and cell-mediated immunity in vivo. J. Immunol. 153: 489-498.
49. Baghestanian, M., H. Agis, D. Bevec, H. C. Bankl, R. Hofbauer, H. G. Kress, J. H. Butterfield, M. R. Muller, L. K. Ashman, W. Fureder, et al. 1996. Stem cell factor-induced downregulation of c-kit in human lung mast cells and HMC-1 mast cells. Exp. Hematol. 24: 1377-1386.
50. Pan, J., I. Copland, M. Post, H. Yeger, and E. Cutz. 2006. Mechanical stretch-induced serotonin release from pulmonary neuroendocrine cells: implications for lung development. Am. J. Physiol. 290: L185-L193.
51. Eddahibi, S., B. Raffestin, I. Pham, J. M. Launay, P. Aegerter, M. Sitbon, and S. Adnot. 1997. Treatment with 5-HT potentiates development of pulmonary hypertension in chronically hypoxic rats. Am. J. Physiol. 272: H1173-H1181.
52. Pitchford, S. C., Y. Riffo-Vasquez, A. Sousa, S. Momi, P. Gresele, D. Spina, and C. P. Page. 2004. Platelets are necessary for airway wall remodeling in a murine model of chronic allergic inflammation. Blood 103: 639-647.
53. Fujimiya, M., K. Okumiya, T. Yamane, and T. Maeda. 1997. Distribution of serotonin-immunoreactive nerve cells and fibers in the rat gastrointestinal tract. Histochem. Cell Biol. 107: 105-114.
54. Oshima, S., M. Fujimura, and M. Fukimiya. 1999. Changes in number of serotonin-containing cells and serotonin levels in the intestinal mucosa of rats with colitis induced by dextran sodium sulfate. Histochem. Cell Biol. 112: 257-263.
55. Gershon, M. D. 2003. Serotonin and its implication for the management of irritable bowel syndrome. Rev. Gastroenterol. Disord. 3(Suppl. 2): S25-S34.
56. Martel, F., R. Monteiro, and C. Lemos. 2003. Uptake of serotonin at the apical and basolateral membranes of human intestinal epithelial (Caco-2) cells occurs through the neuronal serotonin transporter (SERT). J. Pharmacol. Exp. Ther. 306: 355-362.